Tamique Mason

844 total citations · 1 hit paper
8 papers, 472 citations indexed

About

Tamique Mason is a scholar working on Surgery, Obstetrics and Gynecology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tamique Mason has authored 8 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Obstetrics and Gynecology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tamique Mason's work include Pancreatic function and diabetes (5 papers), Diabetes Treatment and Management (4 papers) and Gestational Diabetes Research and Management (4 papers). Tamique Mason is often cited by papers focused on Pancreatic function and diabetes (5 papers), Diabetes Treatment and Management (4 papers) and Gestational Diabetes Research and Management (4 papers). Tamique Mason collaborates with scholars based in Australia, Canada and Norway. Tamique Mason's co-authors include Hwee Teoh, C. David Mazer, Andrew T. Yan, Adrian Quan, Kim A. Connelly, Subodh Verma, Peter Jüni, Fei Zuo, Lawrence A. Leiter and Bernard Zinman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Tamique Mason

8 papers receiving 464 citations

Hit Papers

Effect of Empagliflozin on Left Ventricular Mass in Patie... 2019 2026 2021 2023 2019 100 200 300

Peers

Tamique Mason
Tamique Mason
Citations per year, relative to Tamique Mason Tamique Mason (= 1×) peers Ariana P. Vargas-Delgado

Countries citing papers authored by Tamique Mason

Since Specialization
Citations

This map shows the geographic impact of Tamique Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamique Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamique Mason more than expected).

Fields of papers citing papers by Tamique Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamique Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamique Mason. The network helps show where Tamique Mason may publish in the future.

Co-authorship network of co-authors of Tamique Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Tamique Mason. A scholar is included among the top collaborators of Tamique Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamique Mason. Tamique Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Saadati, Saeede, Daniel Asmelash, Tamique Mason, et al.. (2025). Long‐term effects of metformin on offspring health: A review of current evidence and future directions. Diabetes Obesity and Metabolism. 27(S3). 48–63. 1 indexed citations
2.
Saadati, Saeede, et al.. (2025). Metformin use in women with polycystic ovary syndrome ( PCOS ): Opportunities, benefits, and clinical challenges. Diabetes Obesity and Metabolism. 27(S3). 31–47. 7 indexed citations
3.
Alesi, Simon, Adriana C. H. Neven, Tamique Mason, et al.. (2025). Metabolic associations of human placental lactogen in pregnancies at high metabolic risk: An observational cohort study. Acta Obstetricia Et Gynecologica Scandinavica. 104(9). 1694–1704. 1 indexed citations
4.
Mason, Tamique, et al.. (2024). Metformin in gestational diabetes: physiological actions and clinical applications. Nature Reviews Endocrinology. 21(2). 77–91. 4 indexed citations
5.
Verma, Subodh, Adrian Quan, Chao‐Hung Wang, et al.. (2023). Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 325(5). H1210–H1222. 8 indexed citations
6.
Terenzi, Daniella C., Tamique Mason, Adrian Quan, et al.. (2023). EMPAGLIFLOZIN REDUCED CIRCULATING PRO-INFLAMMATORY PRECURSOR CELL CONTENT IN PEOPLE WITHOUT DIABETES: A SUBSTUDY OF THE EMPA-HEART 2 CARDIOLINK 6 TRIAL. Journal of the American College of Cardiology. 81(8). 2040–2040. 1 indexed citations
7.
Mason, Tamique, Otávio R. Coelho‐Filho, Subodh Verma, et al.. (2021). Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease. JACC. Cardiovascular imaging. 14(6). 1164–1173. 64 indexed citations
8.
Verma, Subodh, C. David Mazer, Andrew T. Yan, et al.. (2019). Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Circulation. 140(21). 1693–1702. 386 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026